Nussbaum Ran Insider Trades

Insider Trading History

Track insider trading activity for Nussbaum Ran. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $110k 10,500 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 10,500 shares
$14.82
$10.50
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $105k 10,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$463k 10,000 shares
$46.31
$10.50
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $105k 10,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$488k 10,000 shares
$48.79
$10.50
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $24M 2,284,612 shares
Last Trade
Nov 29, 2022 Sale (In The Money)Reported as In The Money on SEC Form 4.
$432k 9,090 shares
$47.57
$10.50
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $39.5M 1,485,168 shares
Last Trade
Oct 21, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$545k 47,999 shares
$11.35
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $39.4M 1,481,927 shares
Last Trade
Oct 21, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$545k 47,999 shares
$11.35
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $0 0 shares
Last Trade
Oct 21, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$173k 15,276 shares
$11.35
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $0 0 shares
Last Trade
Oct 21, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$173k 15,276 shares
$11.35
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $0 0 shares
Last Trade
Jun 16, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.7k 2,211 shares
$6.18
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $38.2M 1,437,169 shares
Last Trade
Jun 16, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.7k 2,211 shares
$6.18
$26.60
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $30.2k 20,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 20,000 shares
$10.20
$1.51
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $181k 6,817 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.1k 6,817 shares
$7.06
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $38.2M 1,434,958 shares
Last Trade
Jun 06, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.38k 1,030 shares
$6.19
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $0 0 shares
Last Trade
Jun 06, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.38k 1,030 shares
$6.19
$26.60
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $0 0 shares
Last Trade
Jun 06, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.38k 1,030 shares
$6.19
$26.60
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $87.1k 8,293 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$547k 16,586 shares
$32.95
$10.50
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $181k 6,817 shares
Last Trade
Jun 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 10,000 shares
$17.89
$26.60
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $87.1k 8,293 shares
Last Trade
Jun 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 8,293 shares
$51.48
$10.50
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $30.2k 20,000 shares
Last Trade
May 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 20,000 shares
$59.20
$1.51
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $5.56M 3,679,797 shares
Last Trade
May 13, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$403M 5,925,925 shares
$68.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up